Baxter International | BAX - Ebitda


Baxter International reported $426M in EBITDA for its fiscal quarter ending in September of 2025.





Ebitda Change Date
Abbott USD 3.09B 44M Sep/2025
AngioDynamics USD -369K 2.01M Feb/2025
AtriCure USD 19.86M 2.06M Dec/2025
Avanos Medical USD 10M 73.9M Sep/2025
Baxter International USD 426M 36M Sep/2025
Becton, Dickinson and Co. USD 1.71B 433M Dec/2025
Boston Scientific USD 1.37B 1000K Sep/2025
Cooper Companies USD 336.6M 14.8M Sep/2025
Dexcom USD 422.2M 53.8M Dec/2025
Edwards Lifesciences USD 464.3M 4.7M Sep/2025
Fresenius EUR 850M 22M Sep/2025
Globus Medical USD 252.6M 43.92M Sep/2025
Halozyme Therapeutics USD 21.9M 226.34M Dec/2025
ICU Medical USD 98.19M 27.67M Dec/2025
Insulet USD 194M 34M Dec/2025
Integra LifeSciences USD 78.45M 550.67M Sep/2025
Intuitive Surgical USD 919.7M 21M Sep/2025
J&J USD 9.52B 389M Sep/2025
Laboratory Of America USD 588.1M 24.1M Dec/2025
Masimo USD 72M 42.6M Jun/2025
Medtronic USD 2.93B 482M Dec/2025
Merit Medical Systems USD 79.54M 4.42M Sep/2025
Quest Diagnostics USD 537M 24M Dec/2025
Smith & Nephew USD 796M 139M Dec/2025
Stryker USD 1.67B 206M Sep/2025
Tandem Diabetes Care USD 32.9M 30.13M Dec/2025
Teleflex USD 207.62M 15.28M Jun/2025
Terumo JPY 69.99B 3.22B Dec/2025
Zimmer Biomet Holdings USD 759M 120.8M Dec/2025